Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07836270
PHASE3

A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.

View on ClinicalTrials.gov

Summary

The aim of the study is to evaluate the safety and efficacy of Ecnoglutide injection in overweight or obese Chinese adolescents

Official title: A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Safety and Efficacy of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents (SLIMMER-YOUNG)

Key Details

Gender

All

Age Range

12 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

192

Start Date

2026-10-31

Completion Date

2028-09-30

Last Updated

2026-09-23

Healthy Volunteers

No

Interventions

DRUG

Ecnoglutide Injection

Subcutaneous injection

DRUG

placebo with matching volume

Subcutaneous injection

Locations (1)

Children's Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China